Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Clarium Capital Management is an American investment management firm and hedge fund founded in 2002 by Peter Thiel. The firm primarily follows a global macro strategy, focusing on long-term trends in technology, energy, and geopolitics. While it gained significant prominence for its early success and contrarian bets, the firm saw a substantial decline in assets under management following the 2008 financial crisis. Clarium is known for its thematic approach to investing, often targeting sectors with high growth potential or significant structural shifts. Although not a life sciences company itself, its founder and the firm have been influential in the venture capital and investment landscape for technology and biotechnology startups.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Clarium Capital Management.